One-time use of CB-011, Caribou Biosciences’ off-the-shelf CAR T-cell therapy candidate, showed a manageable safety profile and resulted in lasting responses in adults with…
Myeloma
I see a lot of jargon in my line of work. A big part of my job is helping reporters translate it into something our…
As a caregiver to my mum, who has myeloma, I usually experience some moments of quietness. One of these moments might be when we’re…
The U.S. Food and Drug Administration (FDA) has granted fast track designation to HDP-101 (pamlectabart tismanitin), a multiple myeloma therapy currently in early clinical…
I am a longtime journalist with a firm belief that knowledge is power. My life’s work has been to answer the who, what, where, when,…
The U.S. Food and Drug Administration (FDA) has approved GSK‘s Blenrep (belantamab mafodotin) for adults with relapsed or refractory multiple myeloma. The approval…
“Let me know if you need anything.” No matter how well-intentioned that statement sounds, I personally believe it’s the most useless thing someone can say…
People with hard-to-treat myeloma given a combination of Tecvayli (teclistamab) and Darzalex Faspro (daratumumab and hyaluronidase-fihj) — both approved cancer therapies from…
My therapist advised me to engage in more meditation. A friend sent me a link to a YouTube channel dedicated to yoga. In the waiting…
Results from a clinical trial testing Exicure‘s therapy candidate burixafor (GPC-100) in stem cell transplants for people with myeloma are expected soon — and the developer…
